This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

This study has been completed.
Information provided by (Responsible Party):
Cook Group Incorporated Identifier:
First received: May 16, 2012
Last updated: December 19, 2016
Last verified: December 2016
The objective of this prospective, non-randomized, multicenter, post-market, observational study is to compile clinical data on percutaneous techniques used to obtain tibiopedal access and to cross infrainguinal arterial occlusions.

Condition Intervention
Peripheral Arterial Disease Critical Limb Ischemia Device: Retrograde tibiopedal arterial access

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

Further study details as provided by Cook Group Incorporated:

Primary Outcome Measures:
  • Technical Success deeming tibial pedal arterial access [ Time Frame: 1 - 4 hours post-procedure. ]

Enrollment: 199
Study Start Date: May 2012
Study Completion Date: August 2013
Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Retrograde access Device: Retrograde tibiopedal arterial access
Retrograde, percutaneous arterial access of vessels at or below the tibioperoneal trunk, using a 21 gage needle or micropuncture introducer set, to facilitate crossing and treatment (e.g., angioplasty, stenting, atherectomy) of occlusive arterial lesions in the lower limb.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients will be selected among those presenting with symptoms of peripheral arterial ischemic disease of the lower extremities and for whom endovascular intervention is deemed appropriate.

Inclusion Criteria:

  • Patient has a totally occluded infrainguinal artery, due to peripheral arterial atherosclerotic disease, for which a previous attempt to cross the occlusion using an antegrade approach was unsuccessful. For institutions where tibiopedal access is performed as a primary standard-of-care procedure, a prior unsuccessful antegrade approach attempt is not required.

Exclusion Criteria:

  • Patient will not sign the Informed Consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01609621

United States, Arizona
Interventional Technologies, LLC (Tucson Medical Center)
Tucson, Arizona, United States, 85712
United States, District of Columbia
MedStar Health Research Institute (Washington Hospital Center)
Washington, District of Columbia, United States, 20010
United States, Florida
First Coast Cardiovascular Institute
Jacksonville, Florida, United States, 32216
University of Miami (Mount Sinai Hospital)
Miami, Florida, United States, 33140
United States, Louisiana
Terrebone Medical Center
Houma, Louisiana, United States, 70360
United States, Michigan
Metro Heart and Vascular
Wyoming, Michigan, United States, 49519
United States, North Carolina
Rex Hospital, Inc
Raleigh, North Carolina, United States, 27607
United States, West Virginia
CAMC Health Education and Research Institute, Inc.
Charleston, West Virginia, United States, 25304
Universit ts-Herzzentrum Freiburg - Bad Krozingen GmbH
Bad Krozingen, Germany, 79189
Park-Krankenhaus Leipzig GmbH
Leipzig, Germany, 04289
Casa Di Cura Abano Terme
Abano Herme, Italy, 35031
Sponsors and Collaborators
Cook Group Incorporated
Principal Investigator: Craig Walker, MD Terrebone General Medical Center
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Cook Group Incorporated Identifier: NCT01609621     History of Changes
Other Study ID Numbers: 11-008
Study First Received: May 16, 2012
Last Updated: December 19, 2016

Additional relevant MeSH terms:
Peripheral Arterial Disease
Peripheral Vascular Diseases
Pathologic Processes
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases processed this record on September 18, 2017